On the public citation graph

Li-Fraumeni Syndrome

0 signed · 670 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

1 of the 179 references listed on this page is in the Retraction Watch database as retracted (export 2026-10-28): 10.1158/0008-5472.can-04-1145 (notice 2019-04-15).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.296.22.2727openalex-snapshot
Preimplantation Genetic Diagnosis for Cancer Syndromes
inferredcites →https://doi.org/10.1001/jama.299.11.1315openalex-snapshot
F18-Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography Screening in Li-Fraumeni Syndrome
inferredcites →https://doi.org/10.1002/(sici)1097-0142(19970801)80:3+<569::aid-cncr6>3.0.co;2-4openalex-snapshot
Psychologic aspects of cancer genetic testing
inferredcites →https://doi.org/10.1002/cncr.22834openalex-snapshot
Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age
inferredcites →https://doi.org/10.1002/cncr.26377openalex-snapshot
Early onset HER2‐positive breast cancer is associated with germline TP53 mutations
inferredcites →https://doi.org/10.1002/gepi.1370120103openalex-snapshot
ARCAD: A method for estimating age‐dependent disease risk associated with mutation carrier status from family data
inferredcites →https://doi.org/10.1002/humu.10136openalex-snapshot
Increasing evidence that germline mutations inCHEK2do not cause Li-Fraumeni syndrome
inferredcites →https://doi.org/10.1002/humu.10185openalex-snapshot
GermlineTP53 mutations and Li-Fraumeni syndrome
inferredcites →https://doi.org/10.1002/humu.10218openalex-snapshot
Germline TP53 Mutations and Li-Fraumeni Syndrome
inferredcites →https://doi.org/10.1002/humu.20495openalex-snapshot
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database
inferredcites →https://doi.org/10.1002/humu.21151openalex-snapshot
Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect
inferredcites →https://doi.org/10.1002/ijc.1021openalex-snapshot
Two metachronous tumors in the radiotherapy fields of a patient with Li‐Fraumeni syndrome
inferredcites →https://doi.org/10.1002/j.1460-2075.1990.tb08279.xopenalex-snapshot
Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.
inferredcites →https://doi.org/10.1002/pbc.21836openalex-snapshot
Early detection of adrenocortical carcinoma in a child with Li–Fraumeni syndrome
inferredcites →https://doi.org/10.1002/pon.1352openalex-snapshot
Psychological functioning in persons considering genetic counseling and testing for Li–Fraumeni syndrome
inferredcites →https://doi.org/10.1002/pon.1951openalex-snapshot
Distress in partners of individuals diagnosed with or at high risk of developing tumors due to rare hereditary cancer syndromes
inferredcites →https://doi.org/10.1002/pon.933openalex-snapshot
Psychological impact of genetic testing for cancer susceptibility: an update of the literature
inferredcites →https://doi.org/10.1006/jmbi.1998.1897openalex-snapshot
In vitro analysis of the dominant negative effect of p53 mutants
inferredcites →https://doi.org/10.1006/scbi.1996.0035openalex-snapshot
The p53-deficient mouse: a model for basic and applied cancer studies
inferredcites →https://doi.org/10.1007/s000180050271openalex-snapshot
Covalent and noncovalent modifiers of the p53 protein
inferredcites →https://doi.org/10.1007/s00439-005-0016-xopenalex-snapshot
Generation or birth cohort effect on cancer risk in Li–Fraumeni syndrome
inferredcites →https://doi.org/10.1007/s00439-011-0957-1openalex-snapshot
Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li–Fraumeni syndrome
inferredcites →https://doi.org/10.1007/s00439-011-1039-0openalex-snapshot
Sex-specific effect of the TP53 PIN3 polymorphism on cancer risk in a cohort study of TP53 germline mutation carriers
inferredcites →https://doi.org/10.1007/s100380200055openalex-snapshot
Is there anticipation in the age at onset of cancer in families with Li-Fraumeni syndrome?
inferredcites →https://doi.org/10.1007/s10495-009-0330-1openalex-snapshot
Targeting p53 for enhanced radio- and chemo-sensitivity
inferredcites →https://doi.org/10.1007/s10689-004-1946-5openalex-snapshot
The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li–Fraumeni-like kindreds
inferredcites →https://doi.org/10.1007/s10689-009-9245-9openalex-snapshot
Childhood predictive genetic testing for Li–Fraumeni syndrome
inferredcites →https://doi.org/10.1007/s10689-009-9265-5openalex-snapshot
Attitude towards pre-implantation genetic diagnosis for hereditary cancer
inferredcites →https://doi.org/10.1007/s10689-010-9368-zopenalex-snapshot
Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
inferredcites →https://doi.org/10.1007/s10689-012-9557-zopenalex-snapshot
Routine TP53 testing for breast cancer under age 30: ready for prime time?
inferredcites →https://doi.org/10.1016/0092-8674(79)90293-9openalex-snapshot
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
inferredcites →https://doi.org/10.1016/0092-8674(91)90384-bopenalex-snapshot
Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation
inferredcites →https://doi.org/10.1016/j.ajhg.2010.10.007openalex-snapshot
A Common Molecular Mechanism Underlies Two Phenotypically Distinct 17p13.1 Microdeletion Syndromes
inferredcites →https://doi.org/10.1016/j.cancergencyto.2009.04.014openalex-snapshot
The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations
inferredcites →https://doi.org/10.1016/j.canlet.2005.12.039openalex-snapshot
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families
inferredcites →https://doi.org/10.1016/j.canlet.2007.10.044openalex-snapshot
Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil
inferredcites →https://doi.org/10.1016/j.cell.2004.11.004openalex-snapshot
Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome
inferredcites →https://doi.org/10.1016/j.cell.2004.11.006openalex-snapshot
Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome
inferredcites →https://doi.org/10.1016/j.cell.2004.11.022openalex-snapshot
A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans
inferredcites →https://doi.org/10.1016/j.cell.2011.12.013openalex-snapshot
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
inferredcites →https://doi.org/10.1016/j.ejca.2005.01.026openalex-snapshot
Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations
inferredcites →https://doi.org/10.1016/j.ejca.2005.11.032openalex-snapshot
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives
inferredcites →https://doi.org/10.1016/j.mce.2011.09.010openalex-snapshot
Towards an understanding of the role of p53 in adrenocortical carcinogenesis
inferredcites →https://doi.org/10.1016/j.semradonc.2010.08.008openalex-snapshot
Radiotherapy in the Treatment of Hereditary Breast Cancer
inferredcites →https://doi.org/10.1016/s0002-9440(10)64194-6openalex-snapshot
Variable Levels of Chromosomal Instability and Mitotic Spindle Checkpoint Defects in Breast Cancer
inferredcites →https://doi.org/10.1016/s0002-9440(10)64853-5openalex-snapshot
Development of Spontaneous Mammary Tumors in BALB/c p53 Heterozygous Mice
inferredcites →https://doi.org/10.1016/s0039-6060(03)00410-0openalex-snapshot
Androgen-secreting adrenal tumors
inferredcites →https://doi.org/10.1016/s0140-6736(00)02347-3openalex-snapshot
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation
inferredcites →https://doi.org/10.1016/s0140-6736(03)12856-5openalex-snapshot
Prediction of pathogenic mutations in patients with early-onset breast cancer by family history
inferredcites →https://doi.org/10.1016/s0165-4608(00)00303-4openalex-snapshot
Identification of a novel PTEN intronic deletion in Li-Fraumeni syndrome and its effect on RNA processing
inferredcites →https://doi.org/10.1016/s0304-3835(99)00291-8openalex-snapshot
Analysis of Li–Fraumeni syndrome and Li–Fraumeni-like families for germline mutations in Bcl10
inferredcites →https://doi.org/10.1016/s0960-9822(00)00002-6openalex-snapshot
Tumor spectrum analysis in p53-mutant mice
inferredcites →https://doi.org/10.1016/s1097-2765(00)80002-7openalex-snapshot
Is a p53-Regulated Inhibitor of G2/M Progression
inferredcites →https://doi.org/10.1016/s1470-2045(09)70089-0openalex-snapshot
Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?
inferredcites →https://doi.org/10.1016/s1470-2045(11)70119-xopenalex-snapshot
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study
inferredcites →https://doi.org/10.1016/s1472-6483(10)61953-0openalex-snapshot
Celebrating preimplantation genetic diagnosis of p53 mutations in Li-Fraumeni syndrome
inferredcites →https://doi.org/10.1038/278261a0openalex-snapshot
T antigen is bound to a host protein in SY40-transformed cells
inferredcites →https://doi.org/10.1038/35160openalex-snapshot
Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c
inferredcites →https://doi.org/10.1038/356215a0openalex-snapshot
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
inferredcites →https://doi.org/10.1038/358015a0openalex-snapshot
p53, guardian of the genome
inferredcites →https://doi.org/10.1038/358080a0openalex-snapshot
Amplification of a gene encoding a p53-associated protein in human sarcomas
inferredcites →https://doi.org/10.1038/358083a0openalex-snapshot
Wild-type p53 activates transcription in vitro
inferredcites →https://doi.org/10.1038/370174a0openalex-snapshot
X-rays strike p53 again
inferredcites →https://doi.org/10.1038/387299a0openalex-snapshot
Regulation of p53 stability by Mdm2
inferredcites →https://doi.org/10.1038/bjc.1995.390openalex-snapshot
A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage
inferredcites →https://doi.org/10.1038/bjc.1998.364openalex-snapshot
Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families
inferredcites →https://doi.org/10.1038/ejhg.2009.25openalex-snapshot
Genetic testing in asymptomatic minors
inferredcites →https://doi.org/10.1038/ejhg.2009.26openalex-snapshot
Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics
inferredcites →https://doi.org/10.1038/ng1093-124openalex-snapshot
Screening patients for heterozygous p53 mutations using a functional assay in yeast
inferredcites →https://doi.org/10.1038/ng1097-141openalex-snapshot
KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene
inferredcites →https://doi.org/10.1038/ng1193-225openalex-snapshot
Spontaneous and carcinogen–induced tumorigenesis in p53–deficient mice
inferredcites →https://doi.org/10.1038/ng1282openalex-snapshot
Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice
inferredcites →https://doi.org/10.1038/ng879openalex-snapshot
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
inferredcites →https://doi.org/10.1038/nm0495-302openalex-snapshot
Testing for cancer genes: Decisions, decisions
inferredcites →https://doi.org/10.1038/nrc1235openalex-snapshot
Comparative biology of mouse versus human cells: modelling human cancer in mice
inferredcites →https://doi.org/10.1038/nsb730openalex-snapshot
A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer
inferredcites →https://doi.org/10.1038/sj.bjc.6690313openalex-snapshot
Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li–Fraumeni syndrome
inferredcites →https://doi.org/10.1038/sj.ejhg.5201715openalex-snapshot
The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li–Fraumeni syndrome and related phenotypes
inferredcites →https://doi.org/10.1038/sj.onc.1201041openalex-snapshot
A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li – Fraumeni patients carrying a mutation to the TP53 gene
inferredcites →https://doi.org/10.1038/sj.onc.1201050openalex-snapshot
Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations
inferredcites →https://doi.org/10.1038/sj.onc.1202033openalex-snapshot
Cancer phenotype correlates with constitutional TP53 genotype in families with the Li–Fraumeni syndrome
inferredcites →https://doi.org/10.1038/sj.onc.1202667openalex-snapshot
Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45
inferredcites →https://doi.org/10.1038/sj.onc.1202783openalex-snapshot
p53 compound heterozygosity in a severely affected child with Li-Fraumeni Syndrome
inferredcites →https://doi.org/10.1038/sj.onc.1204369openalex-snapshot
Characterization of germline TP53 splicing mutations and their genetic and functional analysis
inferredcites →https://doi.org/10.1038/sj.onc.1204373openalex-snapshot
The role of tetramerization in p53 function
inferredcites →https://doi.org/10.1038/sj.onc.1204621openalex-snapshot
Relative frequency and morphology of cancers in carriers of germline TP53 mutations
inferredcites →https://doi.org/10.1038/sj.onc.1206155openalex-snapshot
Screening for TP53 rearrangements in families with the Li–Fraumeni syndrome reveals a complete deletion of the TP53 gene
inferredcites →https://doi.org/10.1038/sj.onc.1207396openalex-snapshot
Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes
inferredcites →https://doi.org/10.1038/sj.onc.1209877openalex-snapshot
The CHEK2 gene and inherited breast cancer susceptibility
inferredcites →https://doi.org/10.1053/j.gastro.2005.10.014openalex-snapshot
Prevalence of Early Onset Colorectal Cancer in 397 Patients With Classic Li–Fraumeni Syndrome
inferredcites →https://doi.org/10.1054/bjoc.2000.1167openalex-snapshot
True
inferredcites →https://doi.org/10.1056/nejm199205143262002openalex-snapshot
Germline Mutations of the p53 Tumor-Suppressor Gene in Children and Young Adults with Second Malignant Neoplasms
inferredcites →https://doi.org/10.1056/nejm199209243271309openalex-snapshot
Preimplantation Genetic Diagnosis
inferredcites →https://doi.org/10.1067/msy.2003.145openalex-snapshot
Cystosarcoma phyllodes (phyllodes tumor) of the male breast
inferredcites →https://doi.org/10.1073/pnas.0802970105openalex-snapshot
Excessive genomic DNA copy number variation in the Li–Fraumeni cancer predisposition syndrome
inferredcites →https://doi.org/10.1073/pnas.1431692100openalex-snapshot
Understanding the function–structure and function–mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis
inferredcites →https://doi.org/10.1073/pnas.161479898openalex-snapshot
An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma
inferredcites →https://doi.org/10.1073/pnas.68.4.820openalex-snapshot
Mutation and Cancer: Statistical Study of Retinoblastoma
inferredcites →https://doi.org/10.1073/pnas.76.5.2420openalex-snapshot
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.
inferredcites →https://doi.org/10.1073/pnas.83.1.130openalex-snapshot
The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13).
inferredcites →https://doi.org/10.1073/pnas.89.14.6413openalex-snapshot
Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
inferredcites →https://doi.org/10.1073/pnas.92.9.3963openalex-snapshot
A simple p53 functional assay for screening cell lines, blood, and tumors.
inferredcites →https://doi.org/10.1073/pnas.97.8.4174openalex-snapshot
High metastatic potential in mice inheriting a targeted p53 missense mutation
inferredcites →https://doi.org/10.1080/095530096145139openalex-snapshot
Fibroblasts from Li-Fraumeni patients are resistant to low dose-rate irradiation
inferredcites →https://doi.org/10.1084/jem.188.11.2033openalex-snapshot
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
inferredcites →https://doi.org/10.1086/341943openalex-snapshot
A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer
inferredcites →https://doi.org/10.1086/374567openalex-snapshot
Germline p53 Mutations in a Cohort with Childhood Sarcoma: Sex Differences in Cancer Risk
inferredcites →https://doi.org/10.1093/carcin/bgn044openalex-snapshot
Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers
inferredcites →https://doi.org/10.1093/emboj/17.16.4657openalex-snapshot
Retention of wild‐type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation
inferredcites →https://doi.org/10.1093/jnci/43.6.1365openalex-snapshot
Rhabdomyosarcoma in Children: Epidemiologic Study and Identification of a Familial Caneer Syndrome
inferredcites →https://doi.org/10.1093/jnci/84.15.1156openalex-snapshot
Recommendations on Predictive Testing for Germ Line p53 Mutations Among Cancer-Prone Individuals
inferredcites →https://doi.org/10.1093/jnci/90.8.606openalex-snapshot
Multiple Primary Cancers in Families With Li-Fraumeni Syndrome
inferredcites →https://doi.org/10.1093/jncimonographs/lgi027openalex-snapshot
Preimplantation Genetic Diagnosis (PGD) for Heritable Neoplasia
inferredcites →https://doi.org/10.1093/pch/8.1.42openalex-snapshot
Guidelines for genetic testing of healthy children
inferredcites →https://doi.org/10.1097/00003086-200208000-00011openalex-snapshot
Genetics of Childhood Cancer
inferredcites →https://doi.org/10.1097/01.gim.0000214632.52958.01openalex-snapshot
Evaluation of a decision aid for families considering p53 genetic counseling and testing
inferredcites →https://doi.org/10.1097/01.mph.0000140650.65591.f1openalex-snapshot
Predictive Genetic Testing for Childhood Cancer: Taking the Road Less Traveled By
inferredcites →https://doi.org/10.1097/yco.0b013e3283252d80openalex-snapshot
Psychosocial aspects of genetic testing
inferredcites →https://doi.org/10.1126/science.1589764openalex-snapshot
Oncogenic Forms of p53 Inhibit p53-Regulated Gene Expression
inferredcites →https://doi.org/10.1126/science.1978757openalex-snapshot
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
inferredcites →https://doi.org/10.1126/science.2047879openalex-snapshot
Identification of p53 as a Sequence-Specific DNA-Binding Protein
inferredcites →https://doi.org/10.1126/science.252.5007.827openalex-snapshot
Ultradeep (>300 Kilometers) Ultramafic Xenoliths: Petrological Evidence from the Transition Zone
inferredcites →https://doi.org/10.1126/science.2649981openalex-snapshot
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
inferredcites →https://doi.org/10.1126/science.278.5340.1043openalex-snapshot
Human Cancer Syndromes: Clues to the Origin and Nature of Cancer
inferredcites →https://doi.org/10.1126/science.286.5449.2528openalex-snapshot
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
inferredcites →https://doi.org/10.1126/science.289.5478.357popenalex-snapshot
Screening hCHK2 for Mutations
inferredcites →https://doi.org/10.1126/science.289.5478.359aopenalex-snapshot
Screening hCHK2 for Mutations
inferredcites →https://doi.org/10.1128/jvi.62.10.3903-3906.1988openalex-snapshot
Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen
inferredcites →https://doi.org/10.1128/mcb.17.1.460openalex-snapshot
Proteolytic Cleavage of Human p53 by Calpain: a Potential Regulator of Protein Stability
inferredcites →https://doi.org/10.1128/mcb.21.17.5869-5878.2001openalex-snapshot
c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination
inferredcites →https://doi.org/10.1128/mcb.8.1.461openalex-snapshot
Phosphorylation of p53 in Normal and Simian Virus 40-Transformed NIH 3T3 Cells
inferredcites →https://doi.org/10.1128/mcb.9.9.3982openalex-snapshot
High Incidence of Lung, Bone, and Lymphoid Tumors in Transgenic Mice Overexpressing Mutant Alleles of the p53 Oncogene
inferredcites →https://doi.org/10.1136/bmj.314.7078.441openalex-snapshot
Who should talk to patients with cancer about genetics?
inferredcites →https://doi.org/10.1136/jmg.2004.030551openalex-snapshot
Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation
inferredcites →https://doi.org/10.1136/jmg.2005.037952openalex-snapshot
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome
inferredcites →https://doi.org/10.1136/jmg.2008.057570openalex-snapshot
Molecular basis of the Li–Fraumeni syndrome: an update from the French LFS families
inferredcites →https://doi.org/10.1136/jmg.2008.058958openalex-snapshot
High frequency of de novo mutations in Li–Fraumeni syndrome
inferredcites →https://doi.org/10.1136/jmg.2008.064972openalex-snapshot
Predictive diagnosis of the cancer prone Li–Fraumeni syndrome by accident: new challenges through whole genome array testing
inferredcites →https://doi.org/10.1136/jmg.2009.066704openalex-snapshot
TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li–Fraumeni syndrome: impact on age at first diagnosis
inferredcites →https://doi.org/10.1136/jmg.2010.078113openalex-snapshot
A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations: Table 1
inferredcites →https://doi.org/10.1136/jmg.34.9.746openalex-snapshot
Uptake of genetic testing for cancer predisposition.
inferredcites →https://doi.org/10.1136/jmg.37.8.e13openalex-snapshot
Absence of germline p16 INK4a alterations in p53 wild type Li-Fraumeni syndrome families
inferredcites →https://doi.org/10.1136/jmg.38.1.43openalex-snapshot
Sensitivity and predictive value of criteria for p53germline mutation screening
inferredcites →https://doi.org/10.1136/jmg.38.4.253openalex-snapshot
Detection of 11 germline inactivating TP53 mutations and absence of TP63 andHCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome
inferredcites →https://doi.org/10.1136/jmg.39.11.833openalex-snapshot
Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation
inferredcites →https://doi.org/10.1146/annurev.genom.3.032802.120023openalex-snapshot
M OLECULAR M ECHANISMS FOR G ENOMIC D ISORDERS
inferredcites →https://doi.org/10.1155/2012/786930openalex-snapshot
Genetic Testing for Minors: Comparison between Italian and British Guidelines
inferredcites →https://doi.org/10.1158/0008-5472.427.65.2openalex-snapshot
Genetic Mapping of a Third Li-Fraumeni Syndrome Predisposition Locus to Human Chromosome 1q23
inferredcites →https://doi.org/10.1158/0008-5472.can-04-1145openalex-snapshot
Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function
inferredcites →https://doi.org/10.1158/0008-5472.can-05-0825openalex-snapshot
A Single Nucleotide Polymorphism in the MDM2 Gene: From a Molecular and Cellular Explanation to Clinical Effect
inferredcites →https://doi.org/10.1158/0008-5472.can-05-4247openalex-snapshot
Joint Effects of Germ-Line p53 Mutation and Sex on Cancer Risk in Li-Fraumeni Syndrome
inferredcites →https://doi.org/10.1158/0008-5472.can-06-0180openalex-snapshot
MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner
inferredcites →https://doi.org/10.1158/0008-5472.can-06-3682openalex-snapshot
Younger Age of Cancer Initiation Is Associated with Shorter Telomere Length in Li-Fraumeni Syndrome
inferredcites →https://doi.org/10.1158/0008-5472.can-09-0851openalex-snapshot
Population-Based Estimate of the Contribution of TP53 Mutations to Subgroups of Early-Onset Breast Cancer: Australian Breast Cancer Family Study
inferredcites →https://doi.org/10.1158/1055-9965.1403.13.8openalex-snapshot
Germ Line BAX Alterations Are Infrequent in Li-Fraumeni Syndrome
inferredcites →https://doi.org/10.1182/blood.v87.10.4376.bloodjournal87104376openalex-snapshot
The p53 gene in pediatric therapy-related leukemia and myelodysplasia
inferredcites →https://doi.org/10.1186/1748-717x-5-104openalex-snapshot
Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome
inferredcites →https://doi.org/10.1186/1897-4287-7-4openalex-snapshot
The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype
inferredcites →https://doi.org/10.1186/gm62openalex-snapshot
Copy number variations and cancer
inferredcites →https://doi.org/10.1200/jco.1996.14.5.1730openalex-snapshot
Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
inferredcites →https://doi.org/10.1200/jco.2000.18.10.2135openalex-snapshot
Anticipated Versus Actual Emotional Reactions to Disclosure of Results of Genetic Tests for Cancer Susceptibility: Findings From p53 and BRCA1 Testing Programs
inferredcites →https://doi.org/10.1200/jco.2003.03.189openalex-snapshot
American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility
inferredcites →https://doi.org/10.1200/jco.2007.12.5922openalex-snapshot
CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls
inferredcites →https://doi.org/10.1200/jco.2008.16.6959openalex-snapshot
Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
inferredcites →https://doi.org/10.1200/jco.2008.21.2712openalex-snapshot
Professionals Assess the Acceptability of Preimplantation Genetic Diagnosis and Prenatal Diagnosis for Managing Inherited Predisposition to Cancer
inferredcites →https://doi.org/10.1200/jco.2009.22.7967openalex-snapshot
2009 Version of the Chompret Criteria for Li Fraumeni Syndrome
inferredcites →https://doi.org/10.1200/jco.2009.23.9855openalex-snapshot
Prenatal Diagnosis, Preimplantation Genetic Diagnosis, and Cancer: Was Hamlet Wrong?
inferredcites →https://doi.org/10.1200/jco.2009.27.2112openalex-snapshot
Genetic Testing in Li-Fraumeni Syndrome: Uptake and Psychosocial Consequences
inferredcites →https://doi.org/10.1200/jco.2015.63.0996openalex-snapshot
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility
inferredcites →https://doi.org/10.1371/journal.pone.0010813openalex-snapshot
Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
inferredcites →https://doi.org/10.1542/peds.107.6.1451openalex-snapshot
Ethical Issues With Genetic Testing in Pediatrics
inferredcites →https://doi.org/10.1590/s0004-27302004000500009openalex-snapshot
Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors
inferredcites →https://doi.org/10.1667/0033-7587(2002)157[0158:dccigi]2.0.co;2openalex-snapshot
Delayed Chromosome Changes in Gamma-Irradiated Normal and Li-Fraumeni Fibroblasts
inferredcites →https://doi.org/10.18632/aging.100498openalex-snapshot
Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
inferredcites →https://doi.org/10.2165/00024669-200504040-00008openalex-snapshot
American Society of Clinical Oncology
inferredcites →https://doi.org/10.2217/14796694.4.6.759openalex-snapshot
Potential of Advexin ® : A p53 Gene-Replacement Therapy in Li–Fraumeni Syndrome
inferredcites →https://doi.org/10.3343/kjlm.2008.28.6.493openalex-snapshot
Genetic Counseling Can Influence the Course of a Suspected Familial Cancer Syndrome Patient: From a Case of Li-Fraumeni Like Syndrome with a Germline Mutation in the TP53 Gene
inferredcites →https://doi.org/10.7326/0003-4819-71-4-747openalex-snapshot
Soft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms
inferredcites →https://doi.org/10.7326/0003-4819-88-5-725_6openalex-snapshot
Current Medical Diagnosis and Treatment.

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3960702openalex-extracted
Cancer Surveillance for Patients with Li-Fraumeni Syndrome in Brazil is Cost-Effective
inferred← citeshttps://doi.org/10.1001/jamaoncol.2015.0197openalex-snapshot
GermlineTP53Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry
inferred← citeshttps://doi.org/10.1001/jamaoncol.2016.6389openalex-snapshot
Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome
inferred← citeshttps://doi.org/10.1002/9781118464557.ch67openalex-snapshot
Uncommon Adrenal Tumors in Children and Adolescents
inferred← citeshttps://doi.org/10.1002/9781118592168.ch43openalex-snapshot
Sarcoma of Soft Tissue
inferred← citeshttps://doi.org/10.1002/9781118919408.ch1openalex-snapshot
Recent Development in Methodology for Gene Network Problems and Inferences
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm143openalex-snapshot
Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm143.pub2openalex-snapshot
Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling
inferred← citeshttps://doi.org/10.1002/9781119196235.ch77openalex-snapshot
Uncommon Adrenal Tumors in Children and Adolescents
inferred← citeshttps://doi.org/10.1002/cam4.3427openalex-snapshot
Radiation therapy and secondary malignancy in Li‐Fraumeni syndrome: A hereditary cancer registry study
inferred← citeshttps://doi.org/10.1002/ccr3.2698openalex-snapshot
Breast cancer suspected to originate from familial hereditary tumors: A case report
inferred← citeshttps://doi.org/10.1002/cncr.30703openalex-snapshot
Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors
inferred← citeshttps://doi.org/10.1002/cncr.33922openalex-snapshot
Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor
inferred← citeshttps://doi.org/10.1002/emmm.201101105openalex-snapshot
Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes
inferred← citeshttps://doi.org/10.1002/gcc.22956openalex-snapshot
Single nucleotide polymorphism array‐based signature of low hypodiploidy in acute lymphoblastic leukemia
inferred← citeshttps://doi.org/10.1002/hed.24594openalex-snapshot
Li–Fraumeni syndrome presenting as mucosal melanoma: Case report and treatment considerations
inferred← citeshttps://doi.org/10.1002/humu.22254openalex-snapshot
Drastic Effect of GermlineTP53Missense Mutations in Li-Fraumeni Patients
inferred← citeshttps://doi.org/10.1002/humu.22507openalex-snapshot
Insights into Wild-Type and Mutant p53 Functions Provided by Genetically Engineered Mice
inferred← citeshttps://doi.org/10.1002/humu.22514openalex-snapshot
TP53 Mutants in the Tower of Babel of Cancer Progression
inferred← citeshttps://doi.org/10.1002/humu.23320openalex-snapshot
Higher-than-expected population prevalence of potentially pathogenic germlineTP53variants in individuals unselected for cancer history
inferred← citeshttps://doi.org/10.1002/mgg3.70177openalex-snapshot
Clinical Features and Treatment Strategies of Li‐Fraumeni Syndrome Patients With Inherited TP53 Mutations
inferred← citeshttps://doi.org/10.1002/pbc.20700openalex-snapshot
Malignant triton tumor in a patient with Li‐Fraumeni syndrome and a novel TP53 mutation
inferred← citeshttps://doi.org/10.1002/pbc.24269openalex-snapshot
The germline TP53 mutation c.722 C>T promotes bone and liver tumorigenesis at a young age
inferred← citeshttps://doi.org/10.1002/pbc.31487openalex-snapshot
A Unique Case of a Pediatric Patient with Six Childhood Cancers in Association with a Germline TP53 Gene Pathogenic Variant
inferred← citeshttps://doi.org/10.1002/wsbm.1342openalex-snapshot
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial
inferred← citeshttps://doi.org/10.1007/164_2017_55openalex-snapshot
Natural (and Unnatural) Small Molecules as Pharmacological Chaperones and Inhibitors in Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4419-8044-1_2openalex-snapshot
DNA Damage Signaling Downstream of ATM
inferred← citeshttps://doi.org/10.1007/978-1-4614-3676-8openalex-snapshot
p53 in the Clinics
inferred← citeshttps://doi.org/10.1007/978-1-4614-5116-7_1openalex-snapshot
Epidemiology and Etiology of Breast Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-03952-3_13openalex-snapshot
IER5 Is a p53-Regulated Activator of HSF1 That Contributes to Promotion of Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-62345-6_5222openalex-snapshot
Li-Fraumeni Syndrome
inferred← citeshttps://doi.org/10.1007/978-3-030-66853-2_7openalex-snapshot
Genetic Predispositions and Prophylactic Mastectomy in Breast Cancer Patients
inferred← citeshttps://doi.org/10.1007/978-3-030-71113-9_3-1openalex-snapshot
Predisposing Genetic Variants and Potent Genetic Mutations in Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-74448-9_1openalex-snapshot
Li-Fraumeni Syndrome
inferred← citeshttps://doi.org/10.1007/978-3-030-74448-9_12openalex-snapshot
Inherited Pediatric Cancer in Low- and Intermediate-Resource Countries
inferred← citeshttps://doi.org/10.1007/978-3-030-74448-9_6openalex-snapshot
Wilms Tumor
inferred← citeshttps://doi.org/10.1007/978-3-030-94110-9_17openalex-snapshot
Role of Genetics in Gynaecological Cancers
inferred← citeshttps://doi.org/10.1007/978-3-031-23687-7_8openalex-snapshot
Pediatric Brain and Brainstem Tumors
inferred← citeshttps://doi.org/10.1007/978-3-031-23705-8_7openalex-snapshot
Tumors of Choroid Plexus and Other Ventricular Tumors
inferred← citeshttps://doi.org/10.1007/978-3-031-76882-8_3openalex-snapshot
Predisposing Genetic Variants and Potent Genetic Mutations in Cancer
inferred← citeshttps://doi.org/10.1007/978-3-032-18992-9_19openalex-snapshot
Choroid Plexus Tumors
inferred← citeshttps://doi.org/10.1007/978-3-319-19437-0_5openalex-snapshot
BRCA Patient Population
inferred← citeshttps://doi.org/10.1007/978-3-319-19674-9_28openalex-snapshot
Li-Fraumeni Syndrome
inferred← citeshttps://doi.org/10.1007/978-3-319-28100-1_23-1openalex-snapshot
Non-Odontogenic Bone Pathology
inferred← citeshttps://doi.org/10.1007/978-3-319-28845-1_5222-1openalex-snapshot
Li-Fraumeni Syndrome
inferred← citeshttps://doi.org/10.1007/978-3-319-78762-6_9openalex-snapshot
P53 in Head and Neck Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-642-56889-3_8openalex-snapshot
Hereditärer Brust- und Eierstockkrebs
inferred← citeshttps://doi.org/10.1007/978-3-662-48590-3_4openalex-snapshot
Screening for Genetic Susceptibility to Paediatric Tumours
inferred← citeshttps://doi.org/10.1007/978-94-017-9211-0_1openalex-snapshot
p53 and Hereditary Cancer
inferred← citeshttps://doi.org/10.1007/978-94-017-9421-3_4openalex-snapshot
p53 at the Crossroads Between Stress Response Signaling and Tumorigenesis: From Molecular Mechanisms to Therapeutic Opportunities
inferred← citeshttps://doi.org/10.1007/978-981-10-4726-8_2openalex-snapshot
Transcription Factors as Detection and Diagnostic Biomarkers in Cancer
inferred← citeshttps://doi.org/10.1007/978-981-15-6171-9_5openalex-snapshot
Molecular Mechanisms of Early Breast Cancer
inferred← citeshttps://doi.org/10.1007/s00204-019-02578-4openalex-snapshot
The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro
inferred← citeshttps://doi.org/10.1007/s00216-022-04388-7openalex-snapshot
Electrochemical biosensors for analysis of DNA point mutations in cancer research
inferred← citeshttps://doi.org/10.1007/s00292-017-0365-yopenalex-snapshot
Pathogenese und genetischer Hintergrund des Osteosarkoms
inferred← citeshttps://doi.org/10.1007/s00330-024-10983-2openalex-snapshot
Baseline surveillance in Li Fraumeni syndrome using whole-body MRI: a systematic review and updated meta-analysis
inferred← citeshttps://doi.org/10.1007/s00381-015-2868-2openalex-snapshot
Reply to: Familial syndromes associated with intracranial tumours: a review
inferred← citeshttps://doi.org/10.1007/s00381-023-06112-xopenalex-snapshot
Medulloblastomas, CNS embryonal tumors, and cerebellar mutism syndrome: advances in care and future directions
inferred← citeshttps://doi.org/10.1007/s00401-014-1348-1openalex-snapshot
Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors
inferred← citeshttps://doi.org/10.1007/s00439-017-1845-0openalex-snapshot
Expanding the spectrum of germline variants in cancer
inferred← citeshttps://doi.org/10.1007/s10549-014-3011-xopenalex-snapshot
Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer
inferred← citeshttps://doi.org/10.1007/s10549-017-4531-yopenalex-snapshot
Clinical implications of germline mutations in breast cancer: TP53
inferred← citeshttps://doi.org/10.1007/s10549-018-4938-0openalex-snapshot
A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer
inferred← citeshttps://doi.org/10.1007/s10549-021-06410-5openalex-snapshot
Uptake and timing of bilateral and contralateral risk-reducing mastectomy in women with Li–Fraumeni syndrome
inferred← citeshttps://doi.org/10.1007/s10689-010-9368-zopenalex-snapshot
Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
inferred← citeshttps://doi.org/10.1007/s10689-012-9557-zopenalex-snapshot
Routine TP53 testing for breast cancer under age 30: ready for prime time?
inferred← citeshttps://doi.org/10.1007/s10689-013-9667-2openalex-snapshot
The MDM2 285G–309G haplotype is associated with an earlier age of tumour onset in patients with Li-Fraumeni syndrome
inferred← citeshttps://doi.org/10.1007/s10689-014-9754-zopenalex-snapshot
Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li–Fraumeni syndrome
inferred← citeshttps://doi.org/10.1007/s10689-016-9895-3openalex-snapshot
Evaluation of TP53 Pro72Arg and MDM2 SNP285–SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations
inferred← citeshttps://doi.org/10.1007/s10689-016-9935-zopenalex-snapshot
TP53 and CDKN1A mutation analysis in families with Li–Fraumeni and Li–Fraumeni like syndromes
inferred← citeshttps://doi.org/10.1007/s10689-016-9943-zopenalex-snapshot
Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands
inferred← citeshttps://doi.org/10.1007/s10689-016-9964-7openalex-snapshot
Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?
inferred← citeshttps://doi.org/10.1007/s10689-017-0028-4openalex-snapshot
p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers
inferred← citeshttps://doi.org/10.1007/s10689-019-00153-5openalex-snapshot
Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li–Fraumeni syndrome)
inferred← citeshttps://doi.org/10.1007/s10863-025-10059-wopenalex-snapshot
The Warburg hypothesis and the emergence of the mitochondrial metabolic theory of cancer
inferred← citeshttps://doi.org/10.1007/s10897-015-9905-xopenalex-snapshot
Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li‐Fraumeni Syndrome
inferred← citeshttps://doi.org/10.1007/s10897-018-0288-7openalex-snapshot
Lay Perspectives on Receiving Different Types of Genomic Secondary Findings: a Qualitative Vignette Study
inferred← citeshttps://doi.org/10.1007/s11010-017-2977-1openalex-snapshot
Comprehensive characterization of genes associated with the TP53 signal transduction pathway in various tumors
inferred← citeshttps://doi.org/10.1007/s11033-022-07840-0openalex-snapshot
Frequency of germline genetic variants in women with a personal or family history of breast cancer from Brazil
inferred← citeshttps://doi.org/10.1007/s11060-020-03509-5openalex-snapshot
Epigenetics impacts upon prognosis and clinical management of choroid plexus tumors
inferred← citeshttps://doi.org/10.1007/s11670-012-0232-6openalex-snapshot
Inhibitory effects of 5-Aza-2′-deoxycytidine and trichostatin A in combination with p53-expressing adenovirus on human laryngocarcinoma cells
inferred← citeshttps://doi.org/10.1007/s11899-022-00663-7openalex-snapshot
Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies
inferred← citeshttps://doi.org/10.1007/s12609-018-0282-yopenalex-snapshot
Risk and Prevention for Highly Penetrant Genes
inferred← citeshttps://doi.org/10.1007/s12609-023-00478-2openalex-snapshot
Genetic Considerations in the Locoregional Management of Breast Cancer: a Review of Current Evidence
inferred← citeshttps://doi.org/10.1007/s13577-025-01198-8openalex-snapshot
Establishment and characterization of NCC-OS2-C1: a novel patient-derived cell line of osteosarcoma
inferred← citeshttps://doi.org/10.1007/s40291-013-0020-0openalex-snapshot
Tumor Protein p53 (TP53) Testing and Li-Fraumeni Syndrome
inferred← citeshttps://doi.org/10.1007/s40487-017-0047-1openalex-snapshot
DNA Mutations May Not Be the Cause of Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-800249-0.00008-1openalex-snapshot
Genetically Engineered Mice as Experimental Tools to Dissect the Critical Events in Breast Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-801565-0.00004-4openalex-snapshot
Etio-pathogenesis I
inferred← citeshttps://doi.org/10.1016/b978-0-12-801565-0.00007-xopenalex-snapshot
Etio-Pathogenesis IV
inferred← citeshttps://doi.org/10.1016/b978-0-12-811785-9.00043-0openalex-snapshot
Advances in Sarcoma Genomics and Therapeutic Management
inferred← citeshttps://doi.org/10.1016/b978-0-12-816920-9.00005-5openalex-snapshot
Hereditary predispositions to tumors, tumor suppressor genes, and their clinico-genomic complexities
inferred← citeshttps://doi.org/10.1016/b978-0-12-821567-8.00013-0openalex-snapshot
p53 supplementation as a targeted cancer gene therapy for glioblastoma
inferred← citeshttps://doi.org/10.1016/b978-0-323-47674-4.00013-xopenalex-snapshot
Genetic Factors
inferred← citeshttps://doi.org/10.1016/b978-0-323-48555-5.00007-7openalex-snapshot
Cancer Syndromes That Present in Childhood
inferred← citeshttps://doi.org/10.1016/b978-0-323-52480-3.50100-1openalex-snapshot
Adrenal Cortical Neoplasms in Children
inferred← citeshttps://doi.org/10.1016/bs.acr.2025.08.008openalex-snapshot
An overview of the diagnosis and management of Choroid Plexus tumors
inferred← citeshttps://doi.org/10.1016/j.advms.2016.12.002openalex-snapshot
A novel germline TP53 mutation p.Pro190Arg detected in a patient with lung and bilateral breast cancers
inferred← citeshttps://doi.org/10.1016/j.ajhg.2023.08.014openalex-snapshot
Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy
inferred← citeshttps://doi.org/10.1016/j.ajhg.2026.07.011openalex-snapshot
Shared inheritance reveals landscape of somatic and germline cancer risk in TP53
inferred← citeshttps://doi.org/10.1016/j.ajoms.2019.05.004openalex-snapshot
A rare mandibular osteosarcoma case of Li-Franmeni syndrome with a germline p53R273H mutation
inferred← citeshttps://doi.org/10.1016/j.annpat.2020.02.015openalex-snapshot
Les tumeurs héréditaires de l’ovaire vues par le pathologiste
inferred← citeshttps://doi.org/10.1016/j.bbadis.2024.167612openalex-snapshot
tp53 R217H and R242H mutant zebrafish exhibit dysfunctional p53 hallmarks and recapitulate Li-Fraumeni syndrome phenotypes
inferred← citeshttps://doi.org/10.1016/j.bbcan.2020.188339openalex-snapshot
BRCA1/P53: Two strengths in cancer chemoprevention
inferred← citeshttps://doi.org/10.1016/j.bbcan.2021.188556openalex-snapshot
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting
inferred← citeshttps://doi.org/10.1016/j.bbcan.2022.188843openalex-snapshot
Amazing roles of extrachromosomal DNA in cancer progression
inferred← citeshttps://doi.org/10.1016/j.beem.2026.102099openalex-snapshot
Germline and somatic genetic drivers of adrenocortical tumours
inferred← citeshttps://doi.org/10.1016/j.biocel.2018.12.008openalex-snapshot
Induced pluripotent stem cells: A new strategy to model human cancer
inferred← citeshttps://doi.org/10.1016/j.biochi.2023.09.026openalex-snapshot
Transactivation by partial function P53 family mutants is increased by the presence of G-quadruplexes at a promoter site
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.115256openalex-snapshot
Current progress of pig models for liver cancer research
inferred← citeshttps://doi.org/10.1016/j.breast.2023.02.002openalex-snapshot
A matched case-control study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome (BREAST TP53)
inferred← citeshttps://doi.org/10.1016/j.cancergen.2015.03.004openalex-snapshot
Genomic profile of a Li-Fraumeni-like syndrome patient with a 45,X/46,XX karyotype, presenting neither mutations in TP53 nor clinical stigmata of Turner syndrome
inferred← citeshttps://doi.org/10.1016/j.cancergen.2015.12.012openalex-snapshot
Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome
inferred← citeshttps://doi.org/10.1016/j.cancergen.2019.11.005openalex-snapshot
MIR605 rs2043556 is associated with the occurrence of multiple primary tumors in TP53 p.(Arg337His) mutation carriers
inferred← citeshttps://doi.org/10.1016/j.cancergen.2021.10.002openalex-snapshot
Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel
inferred← citeshttps://doi.org/10.1016/j.canep.2021.101947openalex-snapshot
Individual and neighbourhood socioeconomic measures and the risk of non-central nervous system solid tumours in children: A nationwide register-based case-control study in Denmark
inferred← citeshttps://doi.org/10.1016/j.cell.2026.03.005openalex-snapshot
Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise
inferred← citeshttps://doi.org/10.1016/j.celrep.2015.06.057openalex-snapshot
Systemic Akt1 Deletion after Tumor Onset in p53 Mice Increases Lifespan and Regresses Thymic Lymphoma Emulating p53 Restoration
inferred← citeshttps://doi.org/10.1016/j.celrep.2016.11.007openalex-snapshot
p53 Regulates Progenitor Cell Quiescence and Differentiation in the Airway
inferred← citeshttps://doi.org/10.1016/j.clinthera.2016.03.017openalex-snapshot
Advances in Hereditary Colorectal and Pancreatic Cancers
inferred← citeshttps://doi.org/10.1016/j.clinthera.2016.03.037openalex-snapshot
Cancer Genomics: Targeting Inherited Risk and Somatic Mutations in Precision Oncology
inferred← citeshttps://doi.org/10.1016/j.cllc.2019.11.012openalex-snapshot
High Prevalence of EGFR Mutations in Lung Adenocarcinomas From Brazilian Patients Harboring the TP53 p.R337H Variant
inferred← citeshttps://doi.org/10.1016/j.coisb.2016.12.015openalex-snapshot
Prevalence and penetrance of Li-Fraumeni cancer predisposition syndrome
inferred← citeshttps://doi.org/10.1016/j.ctro.2017.10.004openalex-snapshot
Increasing genomic instability during cancer therapy in a patient with Li-Fraumeni syndrome
inferred← citeshttps://doi.org/10.1016/j.ctrv.2017.11.001openalex-snapshot
Advances in sarcoma gene mutations and therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.dnarep.2019.05.004openalex-snapshot
Crosstalk between P53 and DNA damage response in ageing
inferred← citeshttps://doi.org/10.1016/j.ejca.2019.05.005openalex-snapshot
Reproductive factors associated with breast cancer risk in Li–Fraumeni syndrome
inferred← citeshttps://doi.org/10.1016/j.gene.2023.148069openalex-snapshot
Functional pri-miR-34b/c rs4938723 and KRAS 3′UTR rs61764370 SNPs: Novel phenotype modifiers in Li-Fraumeni Syndrome?
inferred← citeshttps://doi.org/10.1016/j.giec.2021.03.010openalex-snapshot
Inherited Predisposition to Gastric Cancer
inferred← citeshttps://doi.org/10.1016/j.humpath.2017.06.018openalex-snapshot
Pathologic findings in breast, fallopian tube, and ovary specimens in non- BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C , BARD1 , BRIP1 , PALB2 , MUTYH , or CHEK2
inferred← citeshttps://doi.org/10.1016/j.humpath.2018.06.024openalex-snapshot
Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution’s high-risk population
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2018.01.096openalex-snapshot
Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?
inferred← citeshttps://doi.org/10.1016/j.ijscr.2024.110323openalex-snapshot
Her2-positive breast cancer in a young patient with Li-Fraumeni syndrome: A comprehensive case study
inferred← citeshttps://doi.org/10.1016/j.jgg.2021.12.012openalex-snapshot
Characteristics of TP53 germline variants and their correlations with Li-Fraumeni syndrome or Li-Fraumeni-like syndrome in Chinese tumor patients
inferred← citeshttps://doi.org/10.1016/j.jid.2022.02.004openalex-snapshot
Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni Syndrome
inferred← citeshttps://doi.org/10.1016/j.jmb.2022.167663openalex-snapshot
Cancer-related Mutations with Local or Long-range Effects on an Allosteric Loop of p53
inferred← citeshttps://doi.org/10.1016/j.jpedsurg.2016.01.004openalex-snapshot
Risk-reduction surgery in pediatric surgical oncology: A perspective
inferred← citeshttps://doi.org/10.1016/j.lana.2022.100265openalex-snapshot
Cancer surveillance for patients with Li-Fraumeni Syndrome in Brazil: A cost-effectiveness analysis
inferred← citeshttps://doi.org/10.1016/j.lrr.2025.100538openalex-snapshot
Le lymphome cutanée primitif diffus à grandes cellules B : à propos d’un cas Primary cutaneous diffuse large B-cell lymphoma: a case report
inferred← citeshttps://doi.org/10.1016/j.lungcan.2014.11.005openalex-snapshot
EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: Report of two cases and review of the literature
inferred← citeshttps://doi.org/10.1016/j.med.2017.05.001openalex-snapshot
Cáncer de mama
inferred← citeshttps://doi.org/10.1016/j.mpdhp.2012.01.003openalex-snapshot
Li–Fraumeni syndrome: a role for surgical pathologists?
inferred← citeshttps://doi.org/10.1016/j.pan.2022.05.005openalex-snapshot
Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines
inferred← citeshttps://doi.org/10.1016/j.pcl.2014.09.013openalex-snapshot
Genetic and Nongenetic Risk Factors for Childhood Cancer
inferred← citeshttps://doi.org/10.1016/j.phrs.2020.105245openalex-snapshot
p73: From the p53 shadow to a major pharmacological target in anticancer therapy
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2017.05.019openalex-snapshot
CRISPR-engineered genome editing for the next generation neurological disease modeling
inferred← citeshttps://doi.org/10.1016/j.rcl.2021.01.009openalex-snapshot
Imaging of Tumor Syndromes
inferred← citeshttps://doi.org/10.1016/j.rmcr.2018.03.006openalex-snapshot
Multiple metachronous and synchronous malignancies with lung and thorax involvement. Report of two cases
inferred← citeshttps://doi.org/10.1016/j.semcancer.2019.08.021openalex-snapshot
Statistical genomics in rare cancer
inferred← citeshttps://doi.org/10.1016/j.semcancer.2022.02.002openalex-snapshot
Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications
inferred← citeshttps://doi.org/10.1016/j.semcdb.2013.12.014openalex-snapshot
Illuminating p53 function in cancer with genetically engineered mouse models
inferred← citeshttps://doi.org/10.1016/j.soc.2015.06.006openalex-snapshot
The Genetics of Colorectal Cancer
inferred← citeshttps://doi.org/10.1016/j.tranon.2020.100922openalex-snapshot
Bacterial nucleomodulins and cancer: An unresolved enigma
inferred← citeshttps://doi.org/10.1016/j.trecan.2019.11.004openalex-snapshot
Mutant p53 on the Path to Metastasis
inferred← citeshttps://doi.org/10.1016/j.wneu.2018.08.203openalex-snapshot
Pediatric Case of Li-Fraumeni Syndrome Complicated with Supratentorial Anaplastic Ependymoma
inferred← citeshttps://doi.org/10.1016/j.yasu.2014.05.004openalex-snapshot
Screening for Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.yexcr.2014.09.028openalex-snapshot
Studying p53 family proteins in yeast: Induction of autophagic cell death and modulation by interactors and small molecules
inferred← citeshttps://doi.org/10.1016/j.ygyno.2007.03.040openalex-snapshot
Myeloid sarcoma of the vulva as the presenting symptom in a patient with acute myeloid leukemia
inferred← citeshttps://doi.org/10.1016/s0025-7753(07)72466-1openalex-snapshot
Nuevos retos de la oncología molecular en el cáncer de ovario
inferred← citeshttps://doi.org/10.1016/s0246-0467(22)43449-0openalex-snapshot
10.1016/s0246-0467(22)43449-0
inferred← citeshttps://doi.org/10.1016/s0304-5412(13)70517-1openalex-snapshot
Cáncer de mama
inferred← citeshttps://doi.org/10.1016/s1097-2765(02)00527-0openalex-snapshot
Structural and Functional Versatility of the FHA Domain in DNA-Damage Signaling by the Tumor Suppressor Kinase Chk2
inferred← citeshttps://doi.org/10.1016/s2211-033x(22)47101-5openalex-snapshot
Principios del tratamiento quirúrgico de los sarcomas de tejidos blandos
inferred← citeshttps://doi.org/10.1016/s2211-0801(23)00005-5openalex-snapshot
Principi di trattamento chirurgico dei sarcomi dei tessuti molli
inferred← citeshttps://doi.org/10.1021/tx500403topenalex-snapshot
Pyrrolizidine Alkaloids: Potential Role in the Etiology of Cancers, Pulmonary Hypertension, Congenital Anomalies, and Liver Disease
inferred← citeshttps://doi.org/10.1038/ejhg.2013.68openalex-snapshot
Germline copy number variation of genes involved in chromatin remodelling in families suggestive of Li-Fraumeni syndrome with brain tumours
inferred← citeshttps://doi.org/10.1038/nature22312openalex-snapshot
Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations
inferred← citeshttps://doi.org/10.1038/ng.2532openalex-snapshot
The genomic landscape of hypodiploid acute lymphoblastic leukemia
inferred← citeshttps://doi.org/10.1038/npjgenmed.2016.15openalex-snapshot
Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
inferred← citeshttps://doi.org/10.1038/nrclinonc.2014.41openalex-snapshot
Li-Fraumeni syndrome: cancer risk assessment and clinical management
inferred← citeshttps://doi.org/10.1038/nrendo.2017.16openalex-snapshot
Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
inferred← citeshttps://doi.org/10.1038/s41388-020-1361-xopenalex-snapshot
NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity
inferred← citeshttps://doi.org/10.1038/s41392-025-02549-5openalex-snapshot
p53: from understanding its structure to advances in therapeutic targeting
inferred← citeshttps://doi.org/10.1038/s41409-026-02838-9openalex-snapshot
Impact of TP53 alterations on outcomes in pediatric and young adult patients with relapsed / refractory B-cell acute lymphoblastic leukemia after CD19-CAR T-Cell therapy
inferred← citeshttps://doi.org/10.1038/s41416-023-02204-2openalex-snapshot
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
inferred← citeshttps://doi.org/10.1038/s41418-022-00962-9openalex-snapshot
Should mutant TP53 be targeted for cancer therapy?
inferred← citeshttps://doi.org/10.1038/s41418-023-01236-8openalex-snapshot
Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent
inferred← citeshttps://doi.org/10.1038/s41419-021-03638-3openalex-snapshot
Single loss of a Trp53 allele triggers an increased oxidative, DNA damage and cytokine inflammatory responses through deregulation of IκBα expression
inferred← citeshttps://doi.org/10.1038/s41420-017-0009-2openalex-snapshot
Modeling cancer using patient-derived induced pluripotent stem cells to understand development of childhood malignancies
inferred← citeshttps://doi.org/10.1038/s41431-026-02014-zopenalex-snapshot
Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium
inferred← citeshttps://doi.org/10.1038/s41431-026-02061-6openalex-snapshot
Tumor patterns and cancer risk in carriers of TP53 exonic germline variants that alter mRNA splicing
inferred← citeshttps://doi.org/10.1038/s41467-020-17596-5openalex-snapshot
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome
inferred← citeshttps://doi.org/10.1038/s41467-024-51529-wopenalex-snapshot
Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patterns
inferred← citeshttps://doi.org/10.1038/s41467-025-62894-5openalex-snapshot
Peripheral blood DNA methylation predicts the early onset of primary tumor in TP53 mutation carriers
inferred← citeshttps://doi.org/10.1038/s41467-026-73163-4openalex-snapshot
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers
inferred← citeshttps://doi.org/10.1038/s41525-018-0074-3openalex-snapshot
Rare TP53 variant associated with Li-Fraumeni syndrome exhibits variable penetrance in a Saudi family
inferred← citeshttps://doi.org/10.1038/s41556-017-0009-8openalex-snapshot
Mechanical cues control mutant p53 stability through a mevalonate–RhoA axis
inferred← citeshttps://doi.org/10.1038/s41568-020-0265-yopenalex-snapshot
Tumour predisposition and cancer syndromes as models to study gene–environment interactions
inferred← citeshttps://doi.org/10.1038/s41598-017-10333-xopenalex-snapshot
Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas
inferred← citeshttps://doi.org/10.1038/s41598-019-51735-3openalex-snapshot
Radiation-induced malignancies after intensity-modulated versus conventional mediastinal radiotherapy in a small animal model
inferred← citeshttps://doi.org/10.1038/s44320-024-00032-xopenalex-snapshot
Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability
inferred← citeshttps://doi.org/10.1039/c8ra08246dopenalex-snapshot
Design, synthesis, and bioactivity evaluation of antitumor sorafenib analogues
inferred← citeshttps://doi.org/10.1053/j.gastro.2005.10.014openalex-snapshot
Prevalence of Early Onset Colorectal Cancer in 397 Patients With Classic Li–Fraumeni Syndrome
inferred← citeshttps://doi.org/10.1053/j.gastro.2018.10.063openalex-snapshot
Early-Onset Colorectal Cancer in Patients with Li Fraumeni Syndrome: Is It Really Enough to Justify Early Colon Cancer Screening?
inferred← citeshttps://doi.org/10.1053/j.seminoncol.2015.09.015openalex-snapshot
Hereditary cancer syndromes as model systems for chemopreventive agent development
inferred← citeshttps://doi.org/10.1053/j.seminoncol.2016.10.001openalex-snapshot
Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer
inferred← citeshttps://doi.org/10.1053/j.sempedsurg.2005.11.008openalex-snapshot
Malignant adrenal tumors
inferred← citeshttps://doi.org/10.1055/s-0042-1757325openalex-snapshot
The Molecular Genetics of Colorectal Cancer, Hereditary Colorectal Cancer Syndromes, and Early-Onset Colorectal Cancer
inferred← citeshttps://doi.org/10.1056/nejm200012213432508openalex-snapshot
Hyperparathyroid and Hypoparathyroid Disorders
inferred← citeshttps://doi.org/10.1080/14737159.2022.2049247openalex-snapshot
Reviewing the occurrence of large genomic rearrangements in patients with inherited cancer predisposing syndromes: importance of a comprehensive molecular diagnosis
showing the first 200 of 491 · page through all 491
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.